Autoimmune disease in India is rising, and most of the people living with it are still being told the same three things. Take this immunosuppressant. Avoid stress. Live with it. There is a much longer, more useful conversation that almost nobody gets to have. This is that conversation. Hashimoto's, lupus, rheumatoid arthritis, type 1 diabetes, IBD, MS, chronic urticaria, vitiligo, and the others all share more underlying biology than their separate clinic doors suggest.
This is the long, honest read on autoimmune disease as a category, with specific guidance on the parts of the picture that root-cause work can actually move. The clinical management of any specific autoimmune condition still belongs with your specialist. What we add is the upstream story: why the immune system is misfiring in the first place, and what changes the trajectory.
What autoimmune disease actually is
Your immune system is built to recognise self from non-self. When that distinction breaks down, the immune system starts producing antibodies against your own tissues. Each autoimmune disease is named for the tissue under attack. Hashimoto's: thyroid. Lupus: connective tissue, kidneys, skin, joints. Rheumatoid arthritis: synovial joints. Type 1 diabetes: pancreatic beta cells. Coeliac: small intestine, in response to gluten. IBD (Crohn's and ulcerative colitis): different parts of the gut. MS: myelin, the insulation around nerves. Vitiligo: melanocytes in the skin. Chronic urticaria, in many cases: skin mast cells, often with autoimmune drivers.
The diseases look very different on the surface. The biology underneath has more in common than the specialty clinics admit. The immune system has been provoked into a state of low-grade alert. Triggers that should produce a brief, targeted response now produce a persistent, generalised one. Self-tissues, which carry molecular patterns similar to the original trigger, get caught in the fire.
This biology is the reason that lifestyle, gut, sleep, stress, and nutrient interventions move antibody titres, even when the specialist says only the immunosuppressant matters. The specialist is right that the suppressant matters. They are wrong, or at least incomplete, when they say nothing else does.
Autoimmune diseases look different on the surface. The biology underneath has more in common than their separate clinics admit.
Why autoimmune disease is rising
In one generation, the rate of nearly every named autoimmune disease has climbed. The genetics of populations have not changed in one generation. Something in the environment has. Several somethings, actually.
The gut microbiome has changed dramatically. Antibiotic exposure, especially in early childhood, has shifted the microbial communities every Indian child develops. C-section birth rates have climbed, which alters the founding microbiome. Diets have shifted toward less fibre and more refined carbohydrates, which starves the bacteria the immune system co-evolved with. The gut is the largest immune training ground in the body. When it changes, the immune training changes.
Vitamin D status has fallen. Indian women in particular are now overwhelmingly deficient. Vitamin D is one of the central immune-tolerance hormones. Low D is associated with higher rates of nearly every autoimmune disease.
Stress patterns have changed. Chronic, low-grade, unending stress is the new baseline for many adults. The autonomic nervous system spends most of its time in sympathetic dominance. The vagal tone that down-regulates immune activity is reduced. The result is an immune system that runs hot.
Sleep deficit is normalised. Six-and-a-half hours has become the average where seven-and-a-half used to be. Immune regulation happens at night. Less night, more dysregulation.
Environmental exposures. Particulate air pollution, plastic-derived endocrine disruptors, and the residue of agricultural chemicals are all higher than they were a generation ago. None of these is the single cause of autoimmune disease. All of them are part of the soup the immune system swims in.
We cannot reverse all of these factors. We can address the parts of the picture that the patient controls, and we can address them more aggressively than the standard playbook does.
The autoimmune picture as a single story
A useful way to think about autoimmune disease is as a triangle. All three corners need to be present for the disease to manifest.
The first corner is genetic predisposition. Some people carry HLA variants and other genetic backgrounds that make autoimmunity more likely. We cannot change this corner. We can know whether it is there.
The second corner is a trigger. Often an infection. Often a period of intense stress. Sometimes a dietary trigger like gluten in genetically susceptible patients. Sometimes a toxic exposure. The trigger primes the immune system into attack mode, and the attack does not switch off cleanly.
The third corner is a leaky gut. This is the part the standard playbook usually ignores. The intestinal barrier is the gateway through which dietary and microbial molecules cross into circulation. When the barrier is intact, those molecules are processed quietly. When the barrier is leaky, larger molecules cross and the immune system encounters them in a context that produces aggressive antibody formation. Many of those antibodies cross-react with self-tissues. The autoimmune fire is lit.
Treatment of any specific autoimmune disease can target any corner of the triangle. The genetics cannot move. The trigger is often historical. The gut barrier is the corner that can change, and it is where the most leverage lives.
What we test for
Beyond the disease-specific antibody panels (anti-TPO for Hashimoto's, ANA and anti-dsDNA for lupus, anti-CCP and rheumatoid factor for RA, etc.), here is the broader workup we run on every autoimmune patient.
- A comprehensive stool analysis. This is the single highest-yield test in autoimmune work. It maps the microbiome, reads the gut wall, and shows the inflammation markers. Most patients have never had it run.
- Zonulin and faecal calprotectin. Read the gut barrier and the gut inflammation respectively.
- hs-CRP. A simple read on systemic inflammation.
- Vitamin D. Push to above 50 ng/ml in autoimmune patients, sometimes higher under supervision.
- Vitamin B12 and folate. Both affect immune regulation.
- Ferritin. Iron stores and inflammation status in one number.
- Selenium status. Cofactor for thyroid and immune function.
- Omega-3 index, where available. Anti-inflammatory ratio.
- Coeliac panel (anti-tTG IgA, anti-DGP, total IgA). Run in any autoimmune patient with gut symptoms or family history of coeliac.
- EBV titres, in some patients. Reactivated EBV is a common trigger in autoimmune flares.
- Heavy metals, where the history suggests it. Worth investigating in chronic patients with no clear pattern.
- The full disease-specific antibody panel. Tracked over time for trajectory.
The point is not to run every test on every patient. The point is to run the tests that change the plan.
What actually moves the needle
Specialist medication, where indicated, is non-negotiable. We are not asking patients to come off methotrexate or hydroxychloroquine or biologics. We are asking the question of how to give the immune system the best chance of needing less of the medication over time. Most of the leverage comes from these levers.
Gut work. Phase one of any autoimmune protocol in our clinic is gut work. The gut-everything connection and the gut pillar piece are the longer reads on this. The gut is where the autoimmune fire usually begins, and where the most direct intervention lives.
Vitamin D, properly dosed. Most patients need 4,000-8,000 IU daily for a sustained period to reach above 50 ng/ml. We supervise the dose with retesting at month three.
Selenium. 200 mcg daily, ideally from food, lowers anti-TPO antibodies in many Hashimoto's patients over six to twelve months. The data on selenium for other autoimmune conditions is less strong but the cost-benefit is positive.
Omega-3 fatty acids. A high-quality fish oil at 2-3 grams of EPA+DHA per day has consistent anti-inflammatory effects in autoimmune patients. We test the omega-3 index where available, otherwise we dose empirically.
Sleep. We address it aggressively because every other lever pulls at half power without it. Patients who sleep less than seven hours consistently struggle to drop antibody titres, regardless of the rest of the protocol.
Stress. Real stress work, not motivational stress work. Specific structural levers: sleep, exercise dose, alcohol audit, time outdoors, vagal-nerve practices like cold exposure, slow breathing, or specific yoga sequences. Different patients respond to different levers. We pick the one or two that fit the life.
Diet patterns, with care. This is the area most overhyped on the internet. The Autoimmune Protocol (AIP), the carnivore diet, and various other elimination protocols have helped some patients but have also produced a culture of dietary anxiety that does its own harm. We trial structured eliminations for three months in patients with clear autoimmune drivers, then reintroduce systematically. We do not recommend lifelong avoidance based on Instagram.
Targeted supplements. Curcumin in patients with active inflammation. Quercetin in mast-cell-driven pictures. Specific probiotic strains chosen from the stool panel. We do not stack twelve bottles. We pick three to four that match the labs and the picture.
What recovery actually looks like
The trajectory in autoimmune work is slow and non-linear. Antibodies trend down over six to twelve months when the gut, vitamin D, sleep, and stress are addressed. Inflammation markers (hs-CRP, faecal calprotectin) often fall faster, in the first three months. Disease activity scores improve in parallel with the inflammation markers.
For patients on immunosuppressants, dose reduction is sometimes possible under specialist supervision, but it is never our call to make. We coordinate with the rheumatologist, gastroenterologist, or endocrinologist. Reduction usually happens incrementally, with retesting at every step.
For patients in the early autoimmune window (antibody-positive, not yet symptomatic), the trajectory can change dramatically. This is the highest-leverage window in the entire autoimmune story. Catching anti-TPO positivity at TSH 2.5, before any tablet is needed, is a fundamentally different conversation than treating Hashimoto's at TSH 12.
For patients with established disease, the goal is stability, fewer flares, lower medication where possible, and a quality of life that the standard playbook had not been promising. This is real work. It does not deliver a cure. It does meaningfully change the experience of living with the disease.
What we are not promising
We are not promising a cure. Autoimmune diseases, as a category, do not have cures. We are promising that the trajectory bends, that flares become less frequent, that medication doses often come down, that quality of life improves, and that the early window catches more disease before it becomes established.
We are not asking patients to stop their specialist medication. Methotrexate, hydroxychloroquine, biologics, and immunosuppressants have a place. Used at the right dose for the right reason, they are useful. The conversation is whether the dose can come down with the inputs we control. That conversation happens with the specialist, not against them.
We are not running a forever programme. Most autoimmune patients move into a low-touch maintenance pattern after the active 90-180 days. Antibody and inflammation markers are retested every six months for the first two years.
If you have read this far, you are probably more serious about your autoimmune story than the average patient. The work is slow and patient. The body, especially the immune system, responds when the inputs are right, in the right order, given enough time.
